Stocks and Investing Stocks and Investing
Thu, March 7, 2024

John Roberts Maintained (ALB) at Hold with Decreased Target to $112 on, Mar 7th, 2024


Published on 2024-10-28 09:31:33 - WOPRAI, John Roberts
  Print publication without navigation


John Roberts of Mizuho, Maintained "Albemarle Corporation" (ALB) at Hold with Decreased Target from $115 to $112 on, Mar 7th, 2024.

John has made no other calls on ALB in the last 4 months.



There are 12 other peers that have a rating on ALB. Out of the 12 peers that are also analyzing ALB, 7 agree with John's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Chris Parkinson of "Wolfe Research" Initiated at Hold on, Friday, March 1st, 2024
  • Joshua Spector of "UBS" Maintained at Hold with Decreased Target to $125 on, Thursday, February 15th, 2024
  • Patrick Cunningham of "Citigroup" Downgraded from Strong Buy to Hold and Decreased Target to $120 on, Friday, February 9th, 2024
  • David Deckelbaum of "TD Cowen" Downgraded from Buy to Hold and Held Target at $130 on, Monday, January 29th, 2024
  • Christopher Parkinson of "Mizuho" Maintained at Hold with Decreased Target to $130 on, Tuesday, January 23rd, 2024
  • Corinne Blanchard of "Deutsche Bank" Downgraded from Strong Buy to Hold and Decreased Target to $135 on, Thursday, January 11th, 2024
  • Matthew DeYoe of "B of A Securities" Upgraded from Sell to Hold and Decreased Target to $149 on, Tuesday, December 12th, 2023


These are the ratings of the 5 analyists that currently disagree with John


  • Arun Viswanathan of "RBC Capital" Maintained at Buy with Decreased Target to $138 on, Friday, February 16th, 2024
  • Colin Rusch of "Oppenheimer" Maintained at Buy with Decreased Target to $188 on, Friday, February 16th, 2024
  • Michael Sison of "Wells Fargo" Maintained at Buy with Decreased Target to $135 on, Friday, February 16th, 2024
  • Charles Neivert of "Piper Sandler" Downgraded from Hold to Sell and Decreased Target to $128 on, Tuesday, December 5th, 2023
  • Joel Jackson of "BMO Capital" Maintained at Buy with Decreased Target to $180 on, Tuesday, November 7th, 2023
Contributing Sources